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Abstract A patient with HIV and syphilis presents with
bilateral retinal vasculitis and recurrent vitreous hemor-
rhage. Diagnostic and treatment strategies are discussed.
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Case report
A 42-year-old human immunodeficiency virus (HIV)-
infected male on highly active antiretroviral therapy
(HAART) was referred for new floaters in the left eye. He
was diagnosed with HIV 6 years prior when he presented
with disseminated Kaposi’s sarcoma with lymph node
involvement. A year later, he was diagnosed with human
herpes virus 8 (HHV-8)-associated primary effusion lym-
phoma and successfully treated with 6 months of oral
valganciclovir. He had not sustained any opportunistic
infections. The most recent CD4 T-cell count was
720 cells/mm
3, and the HIV viral load was undetectable.
Past medical history included a nonpruritic rash of the
trunk 18 months prior to presentation associated with an RPR
of 1:128. Positron emission tomography–computed tomogra-
phy showed diffuse lymphadenopathy. Subsequent lymph
node biopsy revealed reactive lymphadenitis, thought to be
secondary to syphilis. He was treated twice with three weekly
intramuscular injections of 2.4 million units of benzathine
penicillin (PCN) over the subsequent year.
At presentation, visual acuity was best corrected to 20/25
OD and 20/30 OS. Intraocular pressures were 31 mmHg OD
and 15 mmHg OS. There was no afferent pupillary defect. No
keratic precipitates or posterior synechiae were present in either
eye. The anterior chamber of the right eye exhibited trace
anterior chamber cell and the left eye, 1+ anterior chamber cell.
There was approximately 1+ anterior vitreous cell in the right
eye and 3+ anterior vitreous cell in the left eye. Dilated
funduscopy of the right eye revealed a healthy-appearing optic
nerve with a cup-to-disk ratio of 0.3. Segmental sheathing of
arterioles and venules extended most prominently along the
superotemporal arcades (Fig. 1a). Cotton wool spots were
found throughout the posterior pole. Examination of the left
eye disclosed similar findings (Fig. 1b). Fluorescein angiog-
raphy demonstrated normal arterial filling. The venous filling
in both eyes was segmental and showed areas of perivenous
hypofluorescence (Fig. 1c and d).
An evaluation for causes of retinal vasculitis revealed an
RPR of 1:8 and a positive FTA-ABS. Cytomegalovirus
(CMV) IgG antibody, varicella zoster virus (VZV) IgG,
herpes simplex virus (HSV)-1 IgG, HSV-2 IgG, and
Epstein–Barr virus IgG antibodies were all present. Quan-
titative PCR for Epstein Barr virus and CMV measured
12,456 copies per milliliter and less than 200 copies per
milliliter, respectively. Cardiolipin antibody was not pres-
ent. ANCA screen was negative. ANA was positive with a
titer of 1:80 in a speckled pattern and a titer of 1:40 in a
nucleolar pattern. Protein C and S activity were both
normal. The HLA B51 haplotype was present. A brain
MRI and MRA were both unremarkable.
Intravenous PCN sodium (24 million units daily) was
administered for 14 days. Over the subsequent 6 months, the
RPR titer decreased to 1:4. One month following presentation,
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with retinal neovascularization and vasculitis. Due to the
progression of the eye disease, a lumbar puncture was obtained
which showed a clear cerebrospinal fluid (CSF) without
pleocytosis; CSF analysis including VDRL, cytology, flow
cytometry, and PCR for VZVand HSV was negative.
Six weeks after presentation, a diagnostic vitrectomy
was performed in the left eye. PCR for Mycobacterium
tuberculosis, HSV, HHV-8, toxoplasmosis, VZV, Epstein–
Barr virus, cytomegalovirus, and Treponema pallidum were
all negative. Flow cytometry disclosed only 43 viable cells,
without any definable pattern.
Seven weeks subsequent to presentation, extensive areas of
vascular occlusion were noted on angiography (Fig. 2). Twelve
weeks after presentation, visual acuity remained 20/20 OU.
Fluorescein angiography disclosed areas of persistent occlu-
sive vasculitis, advancing areas of retinal nonperfusion, and
neovascularization. Both eyes were treated with panretinal
laser photocoagulation. Over the subsequent 4 months, the
patient experienced three vitreous hemorrhages in the right
eye and two in the left, all of which resolved with observation.
Further panretinal photocoagulation will be performed in
both eyes, and the therapeutic options considered include
observation, systemic immunosuppression, immunomodu-
lation with interferon, or further treatment for neurosyphilis
with antibiotics and with or without systemic steroids.
Questions:
1. Is syphilis the underlying cause of this patient’s
vasculitis?
2. Is the HLA-B51 haplotype relevant to his disease?
3. Are any other diagnostic studies warranted?
4. Which treatments other than photocoagulation are
likely to be helpful?
Expert comments
Dr. James P. Dunn, Baltimore, MA, USA
1. Is syphilis the underlying cause of this patient’s
vasculitis?
Syphilis remains the most likely diagnosis. The failure
to respond to intramuscular benzathine penicillin reinfor-
ces the premise that ocular syphilis in patients with HIV/
AIDS should always be treated as neurosyphilis, with
high-dose intravenous penicillin (12–24 million units per
day in divided dosages for 10–14 days).
b a
c d
Fig. 1 A 42-year-old HIV-
positive male with recent onset
floaters. Segmental sheathing
and beading of arterioles and
venules extend most prominent-
ly along the superotemporal
arcades in the right eye (a). In
the left eye, sheathing of the
arteries and veins is most prom-
inent along the inferotemporal




filling. The venous filling is
segmental and shows areas of
perivenous hypofluorescence in
the right eye (c) and left eye (d)
90 J Ophthal Inflamm Infect (2011) 1:89–93I would like more information about the patient. For
example, is there any clinical condition to support a
possible diagnosis of Behçet’s disease, such as oral or
cutaneous ulcerations? What medications is the patient
taking? Is there a current history of cigarette smoking?
2. Is the HLA-B51 haplotype relevant to his disease?
The HLA-B51 haplotype is unlikely to be relevant.
Patients with Adamantiades–Behçet’s disease are more
likely to carry this gene than other patients with uveitis,
but this disease is diagnosed clinically. In the absence of
other symptoms (oral ulcers, genital ulcers, cutaneous
hypersensitivity–not the truncal rash described in this
patient–, etc.), which this patient does not appear to have,
I would not consider the HLA-B51 test to be of clinical
significance in this case. It remains unclear what the
predictive positive value of this test is in patients who





Fig. 2 Seven weeks later, the
degree of vascular sheathing,
beading, and tortuosity has
decreased, while intraretinal
hemorrhage and exudate have
increased in both eyes (a and b).
Early-phase fluorescein angiog-
raphy, right eye (c) and left eye
(e), shows a blocking defect by
retinal hemorrhage, vascular
occlusion, and aneurysmal
changes. Early frames of the
nasal retina of the right eye
(d) and left eye (f) show vascu-
lar leakage and global areas of
non-perfusion
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in patients with Behçet’s disease who have ocular
involvement. However, if the B51 test is accorded any
weight, then anti-TNF therapy such as infliximab, which
may be of particular benefit in patients with Behçet’s
disease, could be considered.
3. Are any other diagnostic studies warranted?
I would get a QuantiFERON TB gold test, because
tuberculosis could still be in the differential diagnosis
(although unlikely). HLA-B51 subtypes could be consid-
e r e d ,s u c ha sB 5 1 0 1 ,w h i c hm a yb em o r es u g g e s t i v eo f
Behçet’sd i s e a s e .
4. Which treatments other than photocoagulation are
likely to be helpful?
I would add oral corticosteroids (prednisone) at a
dose of 60 mg/day and would consider intravitreal
therapy, including preservative-free triamcinolone ace-
tonide, 4 mg, or the intravitreal dexamethasone
implant, 750 μg, if oral therapy appears effective but
is not tolerated. In addition, intravitreal anti-VEGF
therapy (bevacizumab or ranibizumab) can also be
considered for the neovascularization, although there is
a risk of worsening the ischemic component.
Dr. Ramana Moorthy, Indianapolis, IN, USA
1. Is syphilis the underlying cause of this patient’s
vasculitis?
Basedonepidemiologic andclinicalevidence,syphilis
is most likely the underlying cause of this patient’s
vasculitis. The incidence of primary and secondary
syphilis is increasing and is particularly prevalent in
men having sex with men, 50–60% of whom are already
known to be HIVinfected [1]. Manifestations of syphilis
are protean but can be atypical in HIV-positive patients.
Occlusive retinal vasculitis can occur [2]. The initial
serologic and clinical evidence suggests inadequately
treated post-primary syphilis in this patient despite
immune reconstitution (CD4=720 cells/mm
3 [3]).
Retreatment with intravenous penicillin reduced serum
RPR titers, but they remained detectable (1:4). The
vasculitis progressed, and retinal neovascularization
developed indicating inadequate response to treatment.
CSF VDRL was negative. Vitreous PCR for Treponema
pallidum was negative.
Other infectious causes of occlusive vasculitis including
tuberculosis, Lyme disease, necrotizing herpetic retinitis
were ruled out serologically or by PCR of intraocular
fluids. Non-infectious systemic causes of occlusive retinal
vasculitis include Behçet’s disease (BD), systemic lupus
erythematosus, Wegener’s granulomatosis, and polyarter-
itis nodosa. All except BD were ruled out by serology.
2. Is the HLA-B51 haplotype relevant to the patient’s
disease?
Although syphilitic retinal vasculitis was suspected
and treated, the disease progressed raising concern about
non-syphilitic causes. Workup revealed the presence of
the HLA-B51 haplotype, raising concern about BD. It is
not a laboratory parameter that I routinely obtain in
patients with retinal vasculitis. The HLA-B51 allele has
a strong association with Behçet’s disease [3]. In the
absence of these non-ocular clinical manifestations,
however, the mere presence of the HLA-B51 haplotype
may not be enough to diagnose BD. To date, here have
been ten reported cases of BD in HIV-infected patients
[4]. Many of the posterior segment ocular opportunistic
infections in HIV-simulated findings of ocular BD [4].
Immunomodulatory therapy was safely utilized in all of
these cases in combination with HAART (to maintain
immune reconstitution and undetectable viral loads) with
the majority of patients recovering from their BD [4].
3. Are any other diagnostic studies warranted?
A thorough review of systems looking at manifes-
tations of BD or systemic vasculitis should be per-
formed. I would recommend a repeat HIV viral load,
CD4 count, and QuantiFERON TB Gold test. Although
there are no other specific diagnostic studies for BD,
cutaneous pathergy testing may be useful.
4. Which other treatments other than photocoagulation are
likely to be helpful?
Since the RPR titer is still low–positive at 1:4, I would
recommend retreatment of the patient based on neuro-
syphilis protocol of 14 days of high doses of intravenous
penicillin therapy to ensure that the RPR serology becomes
negative. I would recommend intravitreal anti-VEGF
therapy (bevacizumab or ranibizumab) and additional
panretinal photocoagulation of untreated areas of angio-
graphic retinal ischemia in each eye for persistent retinal
neovascularization. If this approach fails to control the
retinal vasculitis,then BD or other non-infectious causes of
retinal vasculitis must be considered and immunomodula-
tory therapy instituted with caution. HAART must be
continued. Prednisone, cyclosporine, and colchicine have
all been used with HAART in HIV-positive patients with
BD [4]. Although TNF-α inhibitors (infliximab) are
excellent treatment for ocular BD, the safety of these
agents in patients with HIV infection is unknown. The
immunomodulatory and anti-viral effects of interferon
alpha may be uniquely beneficial in patients with HIVand
BD, but little data exist to recommend such therapy.
Section editor’s note
Albini and colleagues present an interesting case of a
middle-aged man coinfected with HIV and Treponema
pallidum, who presented with severe bilateral retinal
92 J Ophthal Inflamm Infect (2011) 1:89–93vasculitis, progressing despite treatment with intravenous
penicillin.
Indeed, syphilitic uveitis is reemerging, particularly in
association with HIV infection [2, 5, 6]. According to both
invited experts, Drs. Dunn and Moorthy, syphilis is likely
associated with such retinal vaso-occlusive process in this
HIV-infected patient, even despite apparently appropriate
therapy for neurosyphilis. Of note, the RPR titer decreased,
but was still measurable (low titer of 1:4) after treatment,
what might indicate that the patient was not definitely cured.
Even though high-dose intravenous crystalline penicillin is
regarded as the gold-standard therapy for neurosyphilis, there
are concerns about resistance and limited antibiotic penetra-
tion in the CNS [7], as well as inside the eye [8].
Comprehensive investigations revealed positive testing
for HLA-B51, raising the suspicion of a Behçet’s disease
background. The experts are also unanimous that the
presence of HLA-B51 in this patient may be coincidental,
especially in the absence of other signs and symptoms of
Behçet’s disease. In case this positive HLA-B51 result were
to be valued for diagnosing the patient with Behçet’s
disease, Drs. Dunn and Moorthy suggest that appropriate
immunomodulatory therapy would have to be considered,
as has been anecdotally reported in patients with both HIV
and Behçet’s disease [4]. The positive ANA may also raise
some suspicion of lupus erythematosus
Regarding additional testing, an interferon-gamma re-
lease assay would be helpful to exclude tuberculosis,
according to both invited experts. It is also important to
note that a negative PCR for infectious agents does not
definitely exclude them [9].
In addition to the treatment for neurosyphilis with
intravenous crystalline penicillin, Dr. Dunn also suggests
a trial with oral prednisone, 60 mg daily. Dr. Moorthy
would consider immunomodulatory therapy, if the patient
does not respond to retreatment for neurosyphilis with
penicillin. Both experts also suggest intravitreal anti-VEGF
therapy, to control the retinal neovascularization, besides
laser photocoagulation. This should be done with caution,
due to the risk of aggravation of ischemia [10].
We thank Dr. Albini and colleagues for submitting this
interesting case, and the invited experts for their precious
comments.
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